How do you manage reputation during a pharmaceutical product recall?

A pharmaceutical product recall is a high-stakes information event where misinformation can directly affect patient safety, so the reputation work runs tightly alongside regulatory and medical communication. The priority is factual, regulatory-aware customer-facing content that gives patients and providers a clear account of the recall, the affected products, and what to do, coordinated with the FDA notification process. The reputational risk is amplification of inaccuracy: recalls generate fear-driven coverage and social chatter, and AI engines synthesize it into confident answers that may overstate scope or risk. We monitor those answers across the engines with AIQ™ specifically to catch and correct misinformation about the recall’s extent and meaning. The durable work follows the acute phase: authoritative content on the remediation taken and the safety controls now in place, so the public record reflects a company that managed a recall responsibly rather than one defined by the event. In pharma, getting the facts right outranks getting them out fast.